» Articles » PMID: 37566213

Cardio-oncology in China

Overview
Specialty Oncology
Date 2023 Aug 11
PMID 37566213
Authors
Affiliations
Soon will be listed here.
Abstract

Cardio-oncology is going under rapid development in various areas across an increasing number of provinces in China. However there are still a myriad of challenges that need to be overcome in order to ensure its gradual and consistent expansion. The Cardio-Oncology Knowledge Transfer Model (KTM) forms the basis to allow exponential development of effective cardio-oncology services. This would ensure the implementation of precision-based practice while dynamically evolving cardio-oncology to integrate both Western and Chinese medical practices to become an official clinical sub-speciality in its own right in China, for the ultimate benefit of the patient.

Citing Articles

Characteristics, Incidence, and Management of Immune Checkpoint Inhibitors Related Cardiovascular Adverse Events in Real-World Practice-A Retrospective Study in Chinese Han Population.

Wang R, Chen Y, Lou Y, Lu Y, Xu H Ther Clin Risk Manag. 2025; 21:125-135.

PMID: 39980984 PMC: 11840335. DOI: 10.2147/TCRM.S477417.


Cardio-oncology: Examination of progress in China from an oncologist's perspective.

Wang X, Sharma K, Chen Z, Wang S Asia Pac J Oncol Nurs. 2024; 11(6):100491.

PMID: 38845749 PMC: 11153884. DOI: 10.1016/j.apjon.2024.100491.